n-(2-hydroxypropyl)methacrylamide has been researched along with epirubicin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rihova, B | 1 |
| Kopeček, J; Wang, J; Yang, J; Zhang, L; Zhang, R | 1 |
| Fang, Y; Kopeček, J; Yang, J; Zhang, L | 1 |
3 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and epirubicin
| Article | Year |
|---|---|
Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates.
Topics: Acrylamides; Adult; Animals; Antibiotics, Antineoplastic; Biomarkers, Tumor; Breast Neoplasms; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Resistance, Neoplasm; Epirubicin; Female; Hemangiosarcoma; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Immunologic Factors; Middle Aged; Neoplasm Metastasis; Polymethacrylic Acids; Quality of Life; Treatment Outcome | 2009 |
Indium-based and iodine-based labeling of HPMA copolymer-epirubicin conjugates: Impact of structure on the in vivo fate.
Topics: Acrylamides; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Epirubicin; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Mice, Nude; Neoplasms; Staining and Labeling | 2016 |
A new construct of antibody-drug conjugates for treatment of B-cell non-Hodgkin's lymphomas.
Topics: Acrylamides; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Epirubicin; Fluorescent Dyes; Heterografts; Humans; Lymphoma, B-Cell; Male; Mice, SCID; Microscopy, Confocal; Neoplasm Transplantation; Rituximab; Tissue Distribution | 2017 |